Exhibit 99

            LaserSight Signs Agreement With Chinese Strategic Partner

    WINTER PARK, Fla., June 24 /PRNewswire-FirstCall/ --
LaserSight Incorporated (OTC Bulletin Board: LASE) announced today that it has
executed an agreement with Shenzhen New Industries Medical Development Co.
("Shenzhen New Industries"), Shenzhen, the People's Republic of China and its
Hong Kong based-affiliate New Industries Investment Consultants (H.K.) LTD ("New
Industries Investment Consultants"). Shenzhen New Industries is a company that
specializes in advanced medical treatment services, medical device distribution
and medical project investment and New Industries Investment Consultants is the
holder of LaserSight's Series H Convertible Preferred Stock issued during 2002.

      As announced on August 16, 2002, LaserSight and Shenzhen New Industries
entered into a strategic relationship that included the purchase of at least $10
million worth of LaserSight products during a twelve month period ending in
August of 2003, distribution of LaserSight products in mainland China, Hong
Kong, Macao and Taiwan, and a $2 million equity investment in LaserSight
Incorporated by New Industries Investment Consultants. The investment in
LaserSight was in the form of the purchase of Convertible Preferred Stock, the
Series H Stock that, subject to certain restrictions, is convertible into
approximately 40% of LaserSight's Common Stock. Prior to the execution of the
agreement announced today, Shenzhen New Industries had purchased approximately
$4.5 million worth of LaserSight products. As previously announced in its most
recent 10-Q Quarterly Report, the Company had minimal cash and was unable to
manufacture products due to limited inventories and unfavorable financial
relationships with its vendors. The Company and Shenzhen New Industries executed
this agreement in order to start to implement a rescue plan for LaserSight and a
restructuring of LaserSight's governance, management and operations.

      The Company has recently adjusted its business strategy to focus on sales
of the Company's products in China, one of the world's largest markets for laser
vision correction treatment. Under this new business strategy the Company's
operations will be streamlined to improve efficiency and cut costs. The
successful implementation of the new strategy and this restructuring is the key
to improving the Company's cash flow and operating results.

      Under the terms of the agreement, Shenzhen New Industries shall proceed
with further purchase orders and will make efforts to provide necessary advance
payments according to a schedule to be agreed upon between the parties. If
LaserSight's operations are proceeding substantially in accordance with its
restructured business plan, Shenzhen New Industries has indicated that it
intends to purchase additional LaserSight products above and beyond the $10
million in product purchases previously agreed to.

      The Company also announced that Francis E. O'Donnell, Jr., M.D. and David
Peroni have resigned from their positions as members of LaserSight's Board of
Directors and that Dr. O'Donnell has resigned as Chairman of the Company's Board
of Directors. Xianding Weng has been elected Chairman of the Board. Mr. Weng has
been a LaserSight director since October 2002 and founded New Industries
Investment Co., Ltd in Shenzhen, China in 1993 serving as its President and
Chief Executive Officer. This reorganization will facilitate the ability of the
Company to focus on the China market. As previously announced in the Company's
most recent 10-Q Quarterly report, the Company and its Chinese strategic partner
continue to discuss the implementation of a long term business strategy for
China that will allow the Company to share in the recurring revenue stream
generated from the operation of the Company's products.

      This press release contains forward-looking statements regarding future
events and future performance of the Company, including statements with respect
to consummation of a proposed transaction and commercialization of products, all
of which involve risks and uncertainties that could materially affect actual
results. Such statements are based on Management's current expectations and
actual results could differ materially. Investors should refer to documents that
the Company files from time to time with the Securities and Exchange Commission
for a description of certain factors that could cause the actual results to vary
from current expectations and the forward-looking statements contained in this
press release. Such Filing includes, without limitation, the Company's Form
10-K, Form 10-Q and Form 8-K reports.

CONTACT:  Bill Kern, Sr. Vice President - Corporate Development,
          407-678-9900, extension 163, or bkern@lasetech.com

SOURCE  LaserSight Incorporated
    -0-           06/24/2003
/CONTACT:  Bill Kern, Sr. Vice President - Corporate Development, LaserSight
Incorporated, +1-407-678-9900, extension 163, or
bkern@lasetech.com/
    /First Call Analyst: /
    /FCMN Contact: rconfessore@lase.com /